World Health Organization Issues Concern Over Severe Scarcity of Weight-Loss Jabs

Less than one in 10 patients eligible to benefit from obesity jabs such as Wegovy are able to get them, caution the global health agency as it issues its first advice on the therapies.

Given over a billion individuals worldwide currently classified as obese, it is advocating for more widespread and fairer availability to these injectable treatments.

According to projections, more than two billion are projected to be living with obesity by 2030 without intervention.

"The latest guidance recognises that obesity is a long-term condition that can be addressed with holistic and lifelong support," remarked its chief Tedros Adhanom Ghebreyesus.

Significant expense, constrained manufacturing, and logistical bottlenecks are key hurdles to broad access to the injections that can help people shift considerable weight, says the body.

GLP-1 Therapy Scarcity

Despite the current most favorable outlook, the manufacturing of GLP-1 therapies might only reach approximately 100 million people – less than 10% of the global need, as stated by the health organization.

The advice urges nations and manufacturers to expand access, through approaches like licensing agreements.

The intellectual property rights on the active ingredient – the main ingredient of a leading brand – is due to expire in several countries in 2026.

How Weight-Loss Jabs Work

These medications mimick a natural hormone to delay gastric emptying, curb appetite and boost feelings of fullness so individuals reduce food intake.

People commonly see weight reduction in the initial weeks of commencing the regular doses.

Research suggests people may regain a significant portion after a year of discontinuing the medication, when their normal appetite return.

To be above a healthy weight increases your likelihood for developing medical conditions, like type 2 diabetes, heart disease, stroke, and some cancers.

Obesity concerns people in countries worldwide and was responsible for millions of deaths worldwide in 2024, per the WHO.